Reply letter.
暂无分享,去创建一个
[1] A. Oto,et al. Endorectal MRI for risk classification of localized prostate cancer: Radiographic findings and influence on treatment decisions. , 2016, Urologic oncology.
[2] Adam T Froemming,et al. Interobserver Reproducibility of the PI-RADS Version 2 Lexicon: A Multicenter Study of Six Experienced Prostate Radiologists. , 2016, Radiology.
[3] C. Zuiani,et al. Impact of multiparametric magnetic resonance imaging on risk group assessment of patients with prostate cancer addressed to external beam radiation therapy. , 2016, European journal of radiology.
[4] M. Recio,et al. Tumor staging using 3.0 T multiparametric MRI in prostate cancer: impact on treatment decisions for radical radiotherapy , 2015, SpringerPlus.
[5] C. Panje,et al. Guidance of treatment decisions in risk-adapted primary radiotherapy for prostate cancer using multiparametric magnetic resonance imaging: a single center experience , 2015, Radiation oncology.
[6] M. Recio,et al. Role of 3.0 T multiparametric MRI in local staging in prostate cancer and clinical implications for radiation oncology , 2014, Clinical and Translational Oncology.
[7] J. Fütterer,et al. ESUR prostate MR guidelines 2012 , 2012, European Radiology.
[8] M. Aglietta,et al. Comparison of Endorectal Magnetic Resonance Imaging, Clinical Prognostic Factors and Nomograms in the Local Staging of Prostate Cancer Patients Treated with Radiotherapy , 2008 .